Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$2.27M
10 trades · 2 insiders
Net · 90d
$-2.27M
Insiders on file
27
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Crystal Adam | See Remarks | 56 | $0 | $8.54M | 2026-10-01 |
| Newcomb Jessica | Principal Accounting Officer | 6 | $0 | $397.2K | 2026-09-22 |
| Azelby Robert | Director | 2 | $0 | $0 | 2026-06-19 |
| Ketchum John B | Director | 8 | $0 | $0 | 2026-06-05 |
| Rothenberg Mace | Director | 11 | $74.0K | $0 | 2026-06-05 |
| Lee Sung | Director | 6 | $0 | $0 | 2026-06-05 |
| Calhoun Lesley Ann | Director | 10 | $0 | $36.0K | 2026-06-05 |
| Gall Matthew | Chief Financial Officer | 2 | $0 | $0 | 2026-05-01 |
| Weber Barbara | Director, Executive Chair | 16 | $0 | $547.1K | 2026-02-03 |
| Beckman Daniella | Chief Financial Officer | 16 | $0 | $198.7K | 2026-02-03 |
| Peters Malte | President & CEO | 10 | $0 | $0 | 2026-01-08 |
| TRV GP IV, LLC | 10% Owner | 8 | $0 | $18.59M | 2025-10-23 |
| Third Rock Ventures GP IV, L.P. | 10% Owner | 10 | $0 | $24.16M | 2025-08-22 |
| Borisy Alexis | Director | 7 | $0 | $0 | 2025-06-05 |
| Barry Douglas | General Counsel | 11 | $0 | $51.3K | 2025-02-05 |
| EcoR1 Capital, LLC | 10% Owner | 3 | $0 | $8.45M | 2024-11-07 |
| Boxer Capital Management, LLC | Other | 4 | $0 | $20.12M | 2024-11-06 |
| Davis Aaron I. | Other | 8 | $8.72M | $0 | 2024-09-03 |
| Third Rock Ventures IV, L.P. | 10% Owner | 6 | $0 | $9.10M | 2024-08-30 |
| MVA Investors, LLC | Other | 12 | $14.50M | $6.86M | 2024-07-02 |
| Boxer Asset Management Inc. | Other | 2 | $8.72M | $0 | 2023-10-16 |
| Huber Reid M | Director | 3 | $0 | $0 | 2023-06-06 |
| Huang Alan | Chief Scientific Officer | 4 | $0 | $0 | 2023-03-01 |
| Weitzman Aaron | Chief Medical Officer | 1 | $0 | $0 | 2022-12-01 |
| Boxer Capital, LLC | 10% Owner | 3 | $1.04M | $0 | 2022-10-13 |
| LEWIS JOSEPH | 10% Owner | 4 | $714.1K | $0 | 2022-10-06 |
| Rudoltz Marc | Chief Medical Officer | 1 | $0 | $0 | 2021-11-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Crystal Adam | President, R&D | M Exercise deriv | 2026-10-01 | 2026-10-05 | 27,000 | — | $0 | 233,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-10-01 | 2026-10-05 | 600 | $25.32 | $15.2K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-10-01 | 2026-10-05 | 26,400 | $24.45 | $645.6K | 116,343 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-10-01 | 2026-10-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 700 | $22.80 | $16.0K | 66,621 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 5,100 | $23.97 | $122.2K | 61,521 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 2,400 | $25.17 | $60.4K | 59,121 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 2,400 | $25.17 | $60.4K | 59,121 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 5,100 | $23.97 | $122.2K | 61,521 | SEC↗ |
| Newcomb Jessica | Principal Accounting Officer | S Sale | 2026-09-22 | 2026-09-24 | 700 | $22.80 | $16.0K | 66,621 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,000 | — | $0 | 260,040 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-09-01 | 2026-09-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-09-01 | 2026-09-03 | 27,000 | $22.37 | $604.0K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-09-01 | 2026-09-03 | 27,000 | — | $0 | 260,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-09-01 | 2026-09-03 | 27,000 | $22.37 | $603.9K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-09-01 | 2026-09-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-08-03 | 2026-08-05 | 27,000 | — | $0 | 287,040 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-08-03 | 2026-08-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-08-03 | 2026-08-05 | 5,267 | $26.79 | $141.1K | 137,476 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-08-03 | 2026-08-05 | 21,733 | $27.35 | $594.4K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-08-03 | 2026-08-05 | 27,000 | — | $0 | 287,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-08-03 | 2026-08-05 | 21,733 | $27.35 | $594.4K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-08-03 | 2026-08-05 | 5,267 | $26.79 | $141.1K | 137,476 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-08-03 | 2026-08-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-07-01 | 2026-07-02 | 27,000 | — | $0 | 314,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-07-01 | 2026-07-02 | 19,629 | $29.34 | $575.9K | 123,114 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-07-01 | 2026-07-02 | 7,371 | $30.25 | $223.0K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-07-01 | 2026-07-02 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Azelby Robert | Director | A Award deriv | 2026-06-19 | 2026-06-23 | 35,910 | — | $0 | 35,910 | SEC↗ |
| Azelby Robert | Director | A Award | 2026-06-19 | 2026-06-23 | 5,740 | — | $0 | 5,740 | SEC↗ |
| Lee Sung | Director | A Award deriv | 2026-06-05 | 2026-06-08 | 3,570 | — | $0 | 3,570 | SEC↗ |
| Rothenberg Mace | Director | A Award deriv | 2026-06-05 | 2026-06-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award deriv | 2026-06-05 | 2026-06-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Ketchum John B | Director | A Award deriv | 2026-06-05 | 2026-06-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lee Sung | Director | A Award | 2026-06-05 | 2026-06-08 | 570 | — | $0 | 22,870 | SEC↗ |
| Rothenberg Mace | Director | A Award | 2026-06-05 | 2026-06-08 | 4,000 | — | $0 | 41,500 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award | 2026-06-05 | 2026-06-08 | 4,000 | — | $0 | 16,500 | SEC↗ |
| Ketchum John B | Director | A Award | 2026-06-05 | 2026-06-08 | 4,000 | — | $0 | 24,937 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-06-01 | 2026-06-03 | 27,000 | — | $0 | 341,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-06-01 | 2026-06-03 | 6,140 | $22.25 | $136.6K | 136,603 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-06-01 | 2026-06-03 | 20,860 | $23.06 | $481.0K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-06-01 | 2026-06-03 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award deriv | 2026-05-01 | 2026-05-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-05-01 | 2026-05-05 | 27,000 | — | $0 | 368,040 | SEC↗ |
| Gall Matthew | Chief Financial Officer | A Award | 2026-05-01 | 2026-05-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-05-01 | 2026-05-05 | 1,100 | $22.00 | $24.2K | 115,743 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-05-01 | 2026-05-05 | 27,000 | $5.20 | $140.4K | 142,743 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-05-01 | 2026-05-05 | 25,900 | $21.19 | $548.8K | 116,843 | SEC↗ |
| Lee Sung | Director | A Award deriv | 2026-04-29 | 2026-05-01 | 5,200 | — | $0 | 5,200 | SEC↗ |
| Lee Sung | Director | A Award | 2026-04-29 | 2026-05-01 | 12,300 | — | $0 | 22,300 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-04-15 | 2026-04-16 | 38,460 | — | $0 | 395,040 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-04-15 | 2026-04-16 | 38,460 | $25.00 | $961.5K | 112,622 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-04-15 | 2026-04-16 | 38,460 | $5.20 | $200.0K | 151,082 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-04-01 | 2026-04-02 | 27,000 | — | $0 | 433,500 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-04-01 | 2026-04-02 | 27,000 | $5.20 | $140.4K | 139,622 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-04-01 | 2026-04-02 | 27,000 | $21.20 | $572.4K | 112,622 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise deriv | 2026-03-25 | 2026-03-27 | 12,000 | — | $0 | 460,500 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-03-25 | 2026-03-27 | 12,000 | $20.11 | $241.3K | 112,622 | SEC↗ |
| Crystal Adam | President, R&D | M Exercise | 2026-03-25 | 2026-03-27 | 12,000 | $5.20 | $62.4K | 124,622 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-03-05 | 2026-03-09 | 20,251 | $15.00 | $303.8K | 112,622 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-02-25 | 2026-02-27 | 54,345 | $12.77 | $694.0K | 132,873 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-02-03 | 2026-02-04 | 18,251 | $12.26 | $223.8K | 187,419 | SEC↗ |
| Crystal Adam | President, R&D | S Sale | 2026-02-03 | 2026-02-04 | 201 | $12.90 | $2.6K | 187,218 | SEC↗ |
| Weber Barbara | Director, Executive Chair | S Sale | 2026-02-03 | 2026-02-04 | 30,186 | $12.26 | $370.1K | 1,629,587 | SEC↗ |
| Weber Barbara | Director, Executive Chair | S Sale | 2026-02-03 | 2026-02-04 | 333 | $12.90 | $4.3K | 1,629,254 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2026-02-03 | 2026-02-04 | 113 | $12.90 | $1.5K | 184,297 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2026-02-03 | 2026-02-04 | 10,204 | $12.26 | $125.1K | 184,410 | SEC↗ |
| Crystal Adam | President, R&D | A Award deriv | 2026-02-02 | 2026-02-04 | 284,760 | — | $0 | 284,760 | SEC↗ |
| Weber Barbara | Director, Executive Chair | A Award deriv | 2026-02-02 | 2026-02-04 | 222,132 | — | $0 | 222,132 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 265,980 | — | $0 | 265,980 | SEC↗ |
| Crystal Adam | President, R&D | A Award | 2026-02-02 | 2026-02-04 | 47,460 | — | $0 | 205,670 | SEC↗ |
| Weber Barbara | Director, Executive Chair | A Award | 2026-02-02 | 2026-02-04 | 37,522 | — | $0 | 1,659,773 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award | 2026-02-02 | 2026-02-04 | 44,330 | — | $0 | 194,614 | SEC↗ |
| Peters Malte | President & CEO | A Award deriv | 2026-01-08 | 2026-01-12 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| Peters Malte | President & CEO | A Award | 2026-01-08 | 2026-01-12 | 350,000 | — | $0 | 367,500 | SEC↗ |
| Lee Sung | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Lee Sung | Director | A Award | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Peters Malte | Director | A Award deriv | 2025-11-03 | 2025-11-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2025-10-23 | 2025-10-27 | 477,401 | $10.15 | $4.85M | 13,386,574 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2025-09-25 | 2025-09-29 | 500,000 | $8.02 | $4.01M | 13,863,975 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2025-09-16 | 2025-09-17 | 363,541 | $7.04 | $2.56M | 14,363,975 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2025-09-08 | 2025-09-09 | 86,459 | $7.04 | $608.7K | 14,727,516 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2025-09-05 | 2025-09-09 | 642,906 | $7.00 | $4.50M | 14,813,975 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2025-08-22 | 2025-08-26 | 302,194 | $7.00 | $2.12M | 15,456,881 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2025-08-19 | 2025-08-21 | 1,100,000 | $7.01 | $7.71M | 15,759,075 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Ketchum John B | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Rothenberg Mace | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Peters Malte | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Borisy Alexis | Director | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 17,500 | SEC↗ |
| Ketchum John B | Director | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 20,937 | SEC↗ |
| Rothenberg Mace | Director | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 37,500 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 12,500 | SEC↗ |
| Peters Malte | Director | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 17,500 | SEC↗ |
| Weber Barbara | Chief Executive Officer | S Sale | 2025-02-05 | 2025-02-06 | 9,013 | $3.16 | $28.5K | 1,622,251 | SEC↗ |
| Crystal Adam | See Remarks | S Sale | 2025-02-05 | 2025-02-06 | 6,851 | $3.16 | $21.6K | 158,210 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2025-02-05 | 2025-02-06 | 3,948 | $3.16 | $12.5K | 150,284 | SEC↗ |
| Barry Douglas | General Counsel | S Sale | 2025-02-05 | 2025-02-06 | 2,556 | $3.16 | $8.1K | 66,014 | SEC↗ |
| Weber Barbara | Chief Executive Officer | S Sale | 2025-02-04 | 2025-02-06 | 9,778 | $2.99 | $29.2K | 1,631,264 | SEC↗ |
| Crystal Adam | See Remarks | S Sale | 2025-02-04 | 2025-02-06 | 7,432 | $2.99 | $22.2K | 165,061 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2025-02-04 | 2025-02-06 | 4,284 | $2.99 | $12.8K | 154,232 | SEC↗ |
| Barry Douglas | General Counsel | S Sale | 2025-02-04 | 2025-02-06 | 2,774 | $2.99 | $8.3K | 68,570 | SEC↗ |
| Barry Douglas | General Counsel | A Award deriv | 2025-02-03 | 2025-02-05 | 164,175 | — | $0 | 164,175 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award deriv | 2025-02-03 | 2025-02-05 | 635,250 | — | $0 | 635,250 | SEC↗ |
| Crystal Adam | See Remarks | A Award deriv | 2025-02-03 | 2025-02-05 | 318,090 | — | $0 | 318,090 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2025-02-03 | 2025-02-05 | 156,713 | — | $0 | 156,713 | SEC↗ |
| Barry Douglas | General Counsel | A Award | 2025-02-03 | 2025-02-05 | 27,363 | — | $0 | 71,344 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award | 2025-02-03 | 2025-02-05 | 105,875 | — | $0 | 1,641,042 | SEC↗ |
| Crystal Adam | See Remarks | A Award | 2025-02-03 | 2025-02-05 | 53,015 | — | $0 | 172,493 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award | 2025-02-03 | 2025-02-05 | 26,119 | — | $0 | 158,516 | SEC↗ |
| Rothenberg Mace | Director | P Buy | 2024-11-18 | 2024-11-18 | 10,000 | $3.78 | $37.8K | 31,250 | SEC↗ |
| Rothenberg Mace | Director | P Buy | 2024-11-14 | 2024-11-18 | 10,000 | $3.62 | $36.2K | 21,250 | SEC↗ |
| EcoR1 Capital, LLC | 10% Owner | S Sale | 2024-11-07 | 2024-11-08 | 1,143,124 | $2.92 | $3.34M | 10,630,736 | SEC↗ |
| EcoR1 Capital, LLC | 10% Owner | S Sale | 2024-11-07 | 2024-11-08 | 62,318 | $3.29 | $205.0K | 11,773,860 | SEC↗ |
| Boxer Capital Management, LLC | Other | S Sale | 2024-11-06 | 2024-11-07 | 3,080,000 | $3.14 | $9.67M | 3,610,642 | SEC↗ |
| EcoR1 Capital, LLC | 10% Owner | S Sale | 2024-11-06 | 2024-11-08 | 1,494,558 | $3.28 | $4.90M | 11,836,178 | SEC↗ |
| Boxer Capital Management, LLC | Other | S Sale | 2024-10-25 | 2024-10-28 | 633,000 | $6.87 | $4.35M | 6,690,642 | SEC↗ |
| Boxer Capital Management, LLC | Other | S Sale | 2024-10-22 | 2024-10-23 | 250,000 | $6.78 | $1.70M | 7,323,642 | SEC↗ |
| Boxer Capital Management, LLC | Other | S Sale | 2024-10-21 | 2024-10-23 | 625,000 | $7.05 | $4.41M | 7,573,642 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2024-09-13 | 2024-09-17 | 67,400 | $10.53 | $709.7K | 16,859,075 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2024-09-05 | 2024-09-09 | 75,000 | $11.56 | $867.0K | 16,926,475 | SEC↗ |
| Davis Aaron I. | Other | J Other deriv | 2024-09-03 | 2024-09-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-08-30 | 2024-09-04 | 175,000 | $11.60 | $2.03M | 17,001,475 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-08-27 | 2024-08-29 | 25,000 | $11.55 | $288.8K | 17,176,475 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-08-19 | 2024-08-20 | 150,000 | $10.09 | $1.51M | 17,201,475 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-08-16 | 2024-08-20 | 135,000 | $9.79 | $1.32M | 17,351,475 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-08-01 | 2024-08-01 | 40,000 | $9.80 | $392.0K | 17,486,475 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-07-31 | 2024-08-01 | 100,000 | $9.93 | $993.0K | 17,526,475 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-07-30 | 2024-08-01 | 95,000 | $9.80 | $931.0K | 17,626,475 | SEC↗ |
| TRV GP IV, LLC | 10% Owner | S Sale | 2024-07-26 | 2024-07-30 | 50,000 | $9.84 | $492.0K | 17,721,475 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-07-25 | 2024-07-26 | 100,599 | $9.87 | $992.9K | 17,771,475 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-07-24 | 2024-07-26 | 200,000 | $9.82 | $1.96M | 17,872,074 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-07-23 | 2024-07-24 | 125,000 | $9.79 | $1.22M | 18,072,074 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-07-22 | 2024-07-24 | 262,740 | $9.78 | $2.57M | 18,197,074 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-07-18 | 2024-07-22 | 191,490 | $9.81 | $1.88M | 18,459,814 | SEC↗ |
| Third Rock Ventures GP IV, L.P | 10% Owner | S Sale | 2024-07-17 | 2024-07-18 | 550,171 | $9.79 | $5.39M | 18,651,304 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-07-02 | 2024-07-02 | 95,000 | $8.68 | $824.6K | 108,793 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-07-01 | 2024-07-02 | 110,731 | $8.87 | $982.2K | 203,793 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-06-28 | 2024-07-02 | 29,000 | $8.57 | $248.5K | 314,524 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-06-07 | 2024-06-07 | 77,000 | $6.88 | $529.8K | 343,524 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-06-06 | 2024-06-07 | 63,000 | $7.24 | $456.1K | 420,524 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Ketchum John B | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 28,125 | — | $0 | 28,125 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Rothenberg Mace | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Peters Malte | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Borisy Alexis | Director | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| Ketchum John B | Director | A Award | 2024-06-05 | 2024-06-07 | 4,687 | — | $0 | 14,687 | SEC↗ |
| Calhoun Lesley Ann | Director | S Sale | 2024-06-05 | 2024-06-07 | 5,000 | $7.21 | $36.0K | 6,250 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| Rothenberg Mace | Director | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| Peters Malte | Director | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-05-03 | 2024-05-03 | 60,000 | $7.61 | $456.6K | 483,524 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-05-02 | 2024-05-03 | 75,000 | $7.56 | $567.0K | 543,524 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2024-05-01 | 2024-05-03 | 75,000 | $7.43 | $557.3K | 618,524 | SEC↗ |
| Third Rock Ventures IV, L.P. | 10% Owner | S Sale | 2024-02-20 | 2024-02-21 | 162,500 | $12.00 | $1.95M | 19,201,475 | SEC↗ |
| Crystal Adam | See Remarks | S Sale | 2024-02-07 | 2024-02-08 | 4,083 | $12.62 | $51.5K | 119,478 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2024-02-07 | 2024-02-08 | 1,817 | $12.62 | $22.9K | 132,397 | SEC↗ |
| Barry Douglas | General Counsel | S Sale | 2024-02-07 | 2024-02-08 | 1,354 | $12.62 | $17.1K | 43,981 | SEC↗ |
| Weber Barbara | Chief Executive Officer | S Sale | 2024-02-07 | 2024-02-08 | 4,457 | $12.62 | $56.2K | 1,535,167 | SEC↗ |
| Crystal Adam | See Remarks | S Sale | 2024-02-06 | 2024-02-08 | 4,288 | $12.56 | $53.9K | 123,561 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | S Sale | 2024-02-06 | 2024-02-08 | 1,908 | $12.56 | $24.0K | 134,214 | SEC↗ |
| Barry Douglas | General Counsel | S Sale | 2024-02-06 | 2024-02-08 | 1,422 | $12.56 | $17.9K | 45,335 | SEC↗ |
| Weber Barbara | Chief Executive Officer | S Sale | 2024-02-06 | 2024-02-08 | 4,681 | $12.56 | $58.8K | 1,539,624 | SEC↗ |
| Barry Douglas | General Counsel | A Award deriv | 2024-02-01 | 2024-02-05 | 137,156 | — | $0 | 137,156 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award deriv | 2024-02-01 | 2024-02-05 | 523,012 | — | $0 | 523,012 | SEC↗ |
| Crystal Adam | See Remarks | A Award deriv | 2024-02-01 | 2024-02-05 | 279,593 | — | $0 | 279,593 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2024-02-01 | 2024-02-05 | 236,475 | — | $0 | 236,475 | SEC↗ |
| Barry Douglas | General Counsel | A Award | 2024-02-01 | 2024-02-05 | 22,859 | — | $0 | 22,859 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award | 2024-02-01 | 2024-02-05 | 87,168 | — | $0 | 87,168 | SEC↗ |
| Crystal Adam | See Remarks | A Award | 2024-02-01 | 2024-02-05 | 46,599 | — | $0 | 46,599 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award | 2024-02-01 | 2024-02-05 | 39,413 | — | $0 | 39,413 | SEC↗ |
| Crystal Adam | See Remarks | S Sale | 2023-11-01 | 2023-11-02 | 7,507 | $8.39 | $63.0K | 81,250 | SEC↗ |
| Boxer Asset Management Inc. | Other | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| Davis Aaron I. | Other | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| Boxer Asset Management Inc. | Other | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| Davis Aaron I. | Other | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2023-10-09 | 2023-10-11 | 175,000 | $9.97 | $1.74M | 6,948,642 | SEC↗ |
| MVA Investors, LLC | Other | S Sale | 2023-10-09 | 2023-10-11 | 50,000 | $9.91 | $495.5K | 693,524 | SEC↗ |
| Ketchum John B | Director | A Award deriv | 2023-08-29 | 2023-08-31 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Ketchum John B | Director | A Award | 2023-08-29 | 2023-08-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2023-08-11 | 2023-10-11 | 2,340,579 | $5.15 | $12.05M | 2,340,579 | SEC↗ |
| Davis Aaron I. | Director | A Award | 2023-08-11 | 2023-10-11 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| MVA Investors, LLC | Other | P Buy deriv | 2023-08-11 | 2023-08-15 | 2,340,579 | $5.15 | $12.05M | 2,340,597 | SEC↗ |
| MVA Investors, LLC | Other | P Buy | 2023-08-11 | 2023-08-15 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Peters Malte | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Rothenberg Mace | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Davis Aaron I. | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Peters Malte | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Huber Reid M | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Borisy Alexis | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Rothenberg Mace | Director | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Huang Alan | Chief Scientific Officer | A Award deriv | 2023-03-01 | 2023-03-02 | 190,181 | — | $0 | 190,181 | SEC↗ |
| Barry Douglas | General Counsel | A Award deriv | 2023-03-01 | 2023-03-02 | 143,391 | — | $0 | 143,391 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2023-03-01 | 2023-03-02 | 197,051 | — | $0 | 197,051 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award deriv | 2023-03-01 | 2023-03-02 | 537,273 | — | $0 | 537,273 | SEC↗ |
| Crystal Adam | See Remarks | A Award deriv | 2023-03-01 | 2023-03-02 | 487,500 | — | $0 | 487,500 | SEC↗ |
| Huang Alan | Chief Scientific Officer | A Award | 2023-03-01 | 2023-03-02 | 31,697 | — | $0 | 167,584 | SEC↗ |
| Barry Douglas | General Counsel | A Award | 2023-03-01 | 2023-03-02 | 23,898 | — | $0 | 23,898 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award | 2023-03-01 | 2023-03-02 | 32,842 | — | $0 | 96,709 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award | 2023-03-01 | 2023-03-02 | 89,545 | — | $0 | 1,457,137 | SEC↗ |
| Crystal Adam | See Remarks | A Award | 2023-03-01 | 2023-03-02 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Weitzman Aaron | Chief Medical Officer | A Award deriv | 2022-12-01 | 2022-12-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Boxer Capital, LLC | 10% Owner | P Buy | 2022-10-13 | 2022-10-13 | 70,000 | $4.65 | $325.5K | 7,123,642 | SEC↗ |
| Boxer Capital, LLC | 10% Owner | P Buy | 2022-10-12 | 2022-10-13 | 50,000 | $4.43 | $221.5K | 268,524 | SEC↗ |
| Boxer Capital, LLC | 10% Owner | P Buy | 2022-10-11 | 2022-10-13 | 117,000 | $4.25 | $497.3K | 218,524 | SEC↗ |
| LEWIS JOSEPH | 10% Owner | P Buy | 2022-10-06 | 2022-10-06 | 70,394 | $4.06 | $285.8K | 7,053,642 | SEC↗ |
| LEWIS JOSEPH | 10% Owner | P Buy | 2022-10-05 | 2022-10-06 | 45,500 | $3.93 | $178.8K | 6,942,748 | SEC↗ |
| LEWIS JOSEPH | 10% Owner | P Buy | 2022-10-05 | 2022-10-06 | 40,500 | $3.84 | $155.5K | 6,983,248 | SEC↗ |
| LEWIS JOSEPH | 10% Owner | P Buy | 2022-10-04 | 2022-10-06 | 25,606 | $3.67 | $94.0K | 6,897,248 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rothenberg Mace | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Calhoun Lesley Ann | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Peters Malte | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Davis Aaron I. | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Borisy Alexis | Director | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Huang Alan | Chief Scientific Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Barry Douglas | General Counsel | A Award deriv | 2022-02-01 | 2022-02-03 | 69,500 | — | $0 | 69,500 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 625,000 | — | $0 | 625,000 | SEC↗ |
| Rudoltz Marc | Chief Medical Officer | A Award deriv | 2021-11-01 | 2021-11-03 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Beckman Daniella | Chief Financial Officer | A Award deriv | 2021-08-12 | 2021-08-16 | 380,485 | — | $0 | 380,485 | SEC↗ |
| Weber Barbara | Chief Executive Officer | A Award deriv | 2021-08-12 | 2021-08-16 | 961,403 | — | $0 | 961,403 | SEC↗ |
| Huang Alan | Chief Scientific Officer | A Award deriv | 2021-08-12 | 2021-08-16 | 169,859 | — | $0 | 169,859 | SEC↗ |